| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |